7BIO |
 |
| SYNONYMS | (2’Z, 3’E)-7-Bromoindirubin-3’-monoxime MLS2156 |
 |
 |
| PRODUCT LINE | Cell Death / Apoptosis / Autophagy |
 |
 |
| PRODUCT FAMILIES | Non-apoptotic Cell Death / Necrosis |
 |
 |
 |
| Ordering Information |
 |
| Product Numbers | Format | Size | Unit Price | Quantity |  | | ALX-430-149-M005 |
|
5 mg | | | | | ALX-430-149-M025 |
|
25 mg | | | |  |  |  |
|
 |
| Product Specification |
 |
|
| FORMULA: | C16H10BrN3O2 |
 |
 |
| |
|
| MW: | 356.2 |
 |
 |
| |
|
| PURITY: | ≥95% (1H-NMR) |
 |
 |
| |
|
| APPEARANCE: | Dark brown solid. |
 |
 |
| |
|
| SOLUBILITY: | Soluble in DMSO. |
 |
 |
| |
|
| SHIPPING: | AMBIENT |
 |
 |
| |
|
| LONG TERM STORAGE: | -20°C |
 |
 |
| |
|
| HANDLING: | Protect from light. |
 |
 |
| |
|
| HAZARD: | IRRITANT. |
 |
 |
|
 |
| Product Description |
Induces a rapid caspase-independent cell death process distinct from apoptosis. Demonstrated selective inhibition of aurora kinase B (IC50=4.6µM) and aurora kinase C (IC50=0.7µM) whereas the homologeous aurora kinase A is poorly inhibited. |
|
 | | Product Specific Literature References | 3’-Substituted 7-halogenoindirubins, a new class of cell death inducing agents: Y. Ferandin, et al.; J. Med. Chem. 49, 4638 (2006) Abstract 7-Bromoindirubin-3’-oxime induces caspase-independent cell death: J. Ribas, et al.; Oncogene 25, 6304 (2006) Abstract An integrated computational approach to the phenomenon of potent and selective inhibition of aurora kinases B and C by a series of 7-substituted indirubins: V. Myrianthopoulos, et al.; J. Med. Chem. 50, 4027 (2007) Abstract 7-Bromoindirubin-3’-oxime uncovers a serine protease-mediated paradigm of necrotic cell death: J. Ribas, et al.; Biochem. Pharmacol. 76, 39 (2008) Abstract |
|
|
 |
| Related Products |
 |
 | | Indirubin-3'-monoxime |  |  | | Me-7BIO |  |  | | 6BIO |  |  | | Indirubin-5-sulfonic acid . sodium salt |  |  | | Indirubin |  |  | | 5-Iodo-indirubin-3'-monoxime |  |
|
 |
|
| RELATED PRODUCT GROUPS |
Cell Cycle > Kinases in Cell Cycle Regulation > Aurora / Related Products |
 |
 |
 |